Drugs / Serevent® Diskus®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02254174 | Mar → Jul 2006 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Serevent Diskus | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02254174 ↗ |
| Known as | Salmeterol | “50 μg Salmeterol [Serevent® Diskus®]” NCT02254174 ↗ |